Synthesis of Janus gold-magnetic nanoparticles for photothermal cancer therapy
Source abstract
Abstract
Abstract Background . Tumoricidal photothermal therapies by multimodal nanoplatforms with spatiotemporal precision have gained much attention in recent years, however, developing biocompatible, multifunctional nanosystems for real-time tumor targeting and therapy monitoring remains a critical need. Methods . A novel class of epidermal growth factor receptor (EGFR)-specific aptamers modified Janus gold-coated magnetic nanoparticles (GMN) was engineered as a multifunctional nanoplatform for tumor-targeted multimodal imaging and photothermal therapy in this study. Results . The unique Janus nanostructure features of the strategic nanosystem enables dual functionality, firstly for magnetic resonance imaging guidance through the superparamagnetic nanoparticles, secondly for active tumor targeting combined with near-infrared-responsive photothermal ablation mediated by the gold nanostructure. Conclusions . The demonstrated synergistic capabilities of EGFR aptamer modified GMN established a promising platform for developing next-generation theranostic agents to combine precise cancer diagnosis with spatially controlled therapeutic intervention.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Tongji University School of Medicine
Shanghai Lingang Tongji University Intelligent Technology Research Institute
Funding
National Natural Science Foundation of China
References (21)
Show source-provided references
1. Macrophage-mediated delivery of magnetic nanoparticles for enhanced magnetic resonance imaging and magnetothermal therapy of solid tumors10.1016/j.jcis.2022.08.186 ↗
2. Role of magnetic resonance imaging in the evaluation of breast cancer response to neoadjuvant chemotherapy10.21873/invivo.11857 ↗
3. Magnetic iron oxide nanoparticles@lecithin/poly (l-lactic acid) microspheres for targeted drug release in cancer therapy10.1016/j.ijbiomac.2023.127480 ↗
4. Colloidal stability of superparamagnetic iron oxide nanoparticles in the central nervous system: a review10.2217/nnm-2018-0021 ↗
5. Active targeting of gold nanoparticles as cancer therapeutics10.1039/D0CS01121E ↗
6. Intracellular delivery and photothermal therapeutic effects of polyhistidine peptide-modified gold nanoparticles10.1016/j.jbiotec.2022.06.006 ↗
7. Investigation of folate-functionalized magnetic-gold nanoparticles based targeted drug delivery for liver: in Vitro, in vivo and docking studies10.1021/acsbiomaterials.4c01039 ↗
8. Multifunctional plasmonic-magnetic nanoparticles for bioimaging and hyperthermia10.1016/j.addr.2022.114484 ↗
9. Silencing Bag-1 gene via magnetic gold nanoparticle-delivered siRNA plasmid for colorectal cancer therapy in vivo and in vitro10.1007/s13277-016-4926-0 ↗
10. Multifunctional magnetic-gold nanoparticles for efficient combined targeted drug delivery and interstitial photothermal therapy10.1016/j.ijpharm.2018.11.021 ↗
11. Synthesis, transfer, and characterization of core-shell gold-coated magnetic nanoparticles
12. Safe core-satellite magneto-plasmonic nanostructures for efficient targeting and photothermal treatment of tumor cells10.1039/C7NR07844G ↗
13. Gold nanotriangles decorated with superparamagnetic iron oxide nanoparticles: a compositional and microstructural study10.1039/C6FD00028B ↗
14. Janus magnetic-plasmonic nanoparticles for magnetically guided and thermally activated cancer therapy10.1002/smll.201904960 ↗
15. Aptamer-based tumor-targeted diagnosis and drug delivery10.1007/5584_2022_732 ↗
16. Targeted chimera delivery to ovarian cancer cells by heterogeneous gold magnetic nanoparticle10.1088/0957-4484/28/2/025101 ↗
17. Quantitative comparison of the light-to-heat conversion efficiency in nanomaterials suitable for photothermal therapy10.1021/acsami.2c08013 ↗
18. Interplay between EGFR and the platelet-activating factor/PAF receptor signaling axis mediates aggressive behavior of cervical cancer10.3389/fonc.2020.557280 ↗
19. Targeting HER2-mutant metastatic cervical cancer with neratinib: final results from the phase 2 SUMMIT basket trial10.1016/j.ygyno.2023.12.004 ↗
20. Quantum dot-amphipol nanocomplex for intracellular delivery and real-time imaging of siRNA10.1021/nn800280r ↗
21. Cell-penetrating magnetic nanoparticles for highly efficient delivery and intracellular imaging of siRNA10.1021/bm3006903 ↗